Novartis Drug Trileptal Linked to Stevens-Johnson Syndrome

(August 5, 2011) An Illinois man is suing Novartis, the makers of the anticonvulsant drug Trileptal, after it led to his developing of Stevens-Johnson Syndrome, a rare but serious skin disorder. Of the ten claims Justin Roberson brought against Novartis, nine were dismissed by Senior Judge George W. Lindberg of the U.S. District Court for the Northern District of Illinois.

The U.S. Food and Drug Administration approved Trileptal to treat seizures, often to help people who suffer from bipolar disorders or neuropathic pains. They do not, however, approve of Trileptal use in people who are bipolar or have neuropathic pains. Using this medication for the unapproved treatments is considered “off label” use, which has led to many lawsuits.


The only claim Judge Lindberg acknowledged as sufficient was Roberson’s fraud claims. Roberson alleged Novartis misrepresented the safety and effectiveness of Trileptal.


If you or a loved one have taken Trileptal, you may be eligible to file a dangerous drug claim with one of our attorneys. Please take a look at our website, or contact us at 1-800-246-4878 for more information.

Explore posts in the same categories: Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: